News

Neuroscientist Candice Contet and colleagues to take a close look how an understudied brain region promotes alcohol drinking.

"This opens up new options for treating diseases of the blood."

An unexpected discovery in two disease-linked proteins could shed light on human immune system disorders, including a rare and often fatal childhood disease.

This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.

Scripps Research scientists have developed a powerful new strategy for synthesizing molecular skeletons of chemicals used in drugs and other important products

Scientists have discovered that a microscopic roundworm develops similar nerve damage to human patients when their muscle cells are genetically engineered to produce TTR proteins.

"We can now watch antibody responses evolve almost in real time."

New method for precisely controlling 3D architecture of critical linkages used in potential therapeutics.

"This could give us a way to kill tumors without harming normal cells..."

New Scripps Research study offers guidance for more effective Ebola vaccines.

The $75,000 in award funding will support Engle’s work to invent new tools to make new drug candidates quickly, efficiently and sustainably.

"We’re very pleased to have these stellar scientists join our faculty."

"Our study shows an almost threefold improvement in the rate of diagnosis of AFib in the those actively monitored compared to usual care."

There's new evidence that cardiovascular risk factors can be accurately measured and tracked independently outside of a physician’s office using new mobile health technologies.

The researchers estimated that a single human dose of the drugs would convey an insecticide effect against mosquitos and sand flies lasting 50–90 days.

The research offers another approach for tackling diseases that have been considered “undruggable,” including ALS, muscular dystrophy, cystic fibrosis and certain cancers.

"Dr. Sharpless has made numerous contributions to chemistry that have each significantly moved the field forward."

"The big takeaway here is that we have a new molecular target linked to alcohol addiction."

Collaboration will focus on switchable CAR-T therapies aimed primarily at solid tumors.

The work has important implications for understanding how human cancer cells develop resistance to natural product-based chemotherapies. 

Bacteria found in soil may harbor a potential game-changer for drug design. 

The method is likely to be adopted widely for the making of prospective drugs and other chemical products.

Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized ‘miniecosystems’ to quickly see if a molecule can function as a potential therapeutic.

The team found that when the protein that controls the process is defective, in nerve cells in particular, it can allow dangerous, misfolded proteins to accumulate.